Publicaciones en colaboración con investigadores/as de Harvard Medical School (7)

2011

  1. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 108, Núm. 11, pp. 4394-4399